BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 28980417)

  • 1. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
    Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
    Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
    Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
    Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
    Singal V; Singal AK; Kuo YF
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Differences in Gastroenteropancreatic Neuroendocrine Tumor Treatment and Survival in the United States.
    Kessel E; Naparst M; Alpert N; Diaz K; Ahn E; Wolin E; Taioli E; Kim MK
    Pancreas; 2021 Jan; 50(1):29-36. PubMed ID: 33370020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
    Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.
    Nipp R; Tramontano AC; Kong CY; Pandharipande P; Dowling EC; Schrag D; Hur C
    Cancer Med; 2018 Feb; 7(2):525-535. PubMed ID: 29322643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
    DePalo DK; Lee RM; Lopez-Aguiar AG; Gamboa AC; Rocha F; Poultsides G; Dillhoff M; Fields RC; Idrees K; Nathan H; Abbott D; Maithel SK; Russell MC;
    J Surg Oncol; 2019 Nov; 120(6):919-925. PubMed ID: 31385621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
    Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
    Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
    Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in brain cancer characteristics and survival: an analysis of SEER data.
    Bytnar JA; Lin J; Shriver CD; Zhu K
    Cancer Causes Control; 2019 Dec; 30(12):1283-1291. PubMed ID: 31641915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
    Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Zhou H; Zhang Y; Song Y; Tan W; Qiu Z; Li S; Chen Q; Gao S
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):476-486. PubMed ID: 28416359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities in young women with endometrial cancer.
    Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of black/white differences in colon cancer survival.
    Mayberry RM; Coates RJ; Hill HA; Click LA; Chen VW; Austin DF; Redmond CK; Fenoglio-Preiser CM; Hunter CP; Haynes MA
    J Natl Cancer Inst; 1995 Nov; 87(22):1686-93. PubMed ID: 7473817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Tumor Size on Pancreatic Neuroendocrine Tumor Recurrence May Have Racial Variance.
    Zheng-Pywell R; Fang A; AlKashash A; Awad S; Reddy S; Vickers S; Heslin M; Dudeja V; Chen H; Rose JB
    Pancreas; 2021 Mar; 50(3):347-352. PubMed ID: 33835965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
    JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.